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METHODS: In the stepped wedge design, participating
sites were randomly allocated from Control to Training
then Intervention conditions. Thirty-seven health profes-
sionals completed manual-based training and skill devel-
opment before delivering up to four therapy sessions to
70 patients with HADS scores of 8 to 21. The primary
outcome was difference in HADS scores from baseline
to 10-week follow-up. Secondary outcomes were quality
of life (FACT-G; EQ-5D), supportive care needs
(Supportive Care Needs Survey), and Demoralisation
(Demoralisation Scale). RESULTS: Baseline measures
were obtained for 469 patients. The majority were female
(70%) and married, and 32.8% had advanced disease.
Mean HADS scores were 8.8 (SD=6.30) and 8.6
(SD5.90) for Intervention and Control groups, respec-
tively (p=0.59). At follow-up, there was no significance
difference in total HADS scores between Control and
Intervention groups. Higher baseline depression score
was predictive of improvement (p<0.001). Improvement
in anxiety was predicted by higher baseline anxiety score
(p<0.001) and lower FACT functional well-being score
(p<0.001). Patients with advanced disease were more
likely than those with early disease to experience
reduction in supportive care needs. CONCLUSIONS:
Frontline health professionals can provide psychosocial
care, but interventions should target those most likely to
benefit rather than being generically applied.
Research Implications: These results provide prelimi-
nary evidence of the characteristics of patients who are
most likely to benefit from a brief psychosocial interven-
tion integrated into clinical care. Further analysis is
required of the specific types of therapy which are most
likely to be of benefit for depressed cancer patients.
Practice Implications: Integration of psychosocial care
into routine cancer care can be achieved through a model
of care in which frontline health professionals who have
participated in focused training and skill development
provide brief tailored therapy.
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BACKGROUND/PURPOSE: Depression in cancer pa-
tients may impact the course of care and health systems.
Depression may increase 1-year healthcare costs by nearly
41% in medical patients by way of increased office visits,
increased likelihood of visiting emergency rooms, and/or
readmissions within 30 days of discharge. The present
study examined the increased risk that depression confers
on healthcare use in cancer patients. METHODS: A
retrospective chart review was done on 7332 University
of California San Diego (UCSD) Healthcare System
patients with a diagnosis of any cancer in 2011. Using
ICD-9 codes, patients were coded as depressed (n=632)
or nondepressed (n=6700). Total number of visits to the
UCSD healthcare system for 2011 was calculated, and
participants were coded as having an ER visit (yes/no)
or 30-day readmission (yes/no) during 2011. A probabilis-
tic index was computed to determine the probability that a
randomly selected depressed patient had more visits than a
randomly selected nondepressed patient. Odds ratios were
computed for ER visits and 30-day readmissions.
RESULTS: Results showed a 73% probability that
depressed cancer patients had more healthcare visits than
nondepressed patients (p< .001). Depressed patients were
more likely to visit the ER (OR=2.98; 95% CI=2.45–
3.63) and experience a 30-day hospital readmission
(OR=2.32; 95% CI=1.96–2.75) relative to nondepressed
patients. CONCLUSIONS: Results suggest that depres-
sion among cancer patients confers a significant risk for
greater healthcare use. Identification and treatment of
depression may reduce overall healthcare costs and
burden to healthcare systems.
Research Implications: Longitudinal studies are needed
to determine if reduction of depressive symptoms, or
remission of depression, reduces overall healthcare use
and costs.
Practice Implications: Healthcare teams who treat cancer
patients may wish to screen for depression and refer to
psychosocial services to manage depressive symptoms
and reduce overall healthcare costs.
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BACKGROUND/PURPOSE: This feasibility study aimed
to identify whether different types of exercise provide
similar reductions in depression symptoms to cancer survi-
vors with elevated depression, compared to control.
METHODS: 32 participants (58.9±9.4 years) were
allocated to a 12-week clinic-based, supervised exercise
group (n=10), an unsupervised, home-based exercise
group (n=8), or a usual care control group (n=14). The
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supervised group performed two combined resistance and
aerobic sessions weekly. Home-based participants were
provided with printed material about benefits of exercise
and were encouraged to complete 150 min of exercise
weekly. Controls received no exercise or printed material
and were encouraged to maintain usual activity. RESULTS:
Both home-based (6.4± 5.3 to 2.2± 2.9, p= .006) and
supervised (6.9 ± 4.2 to 4.0± 2.4, p= .021) interventions
effectively reduced HADS-D scores compared to control
(7.2 ± 2.5 to 7.7 ± 3.6). Not only did the home-based
group decrease depression to a greater extent but also
more rapidly. HADS-D scores at week 6 were 3.4 ± 3.5
and 6.1 ± 4.2 for the home-based and supervised groups,
respectively (d=0.50). CONCLUSIONS: The rate of
exercise-related reductions in depression was influenced
by the modality of exercise. Psychological mechanisms
such as mastery and distraction may have accounted for
initial rapid improvements in the home-based group.
However, increasing the duration of the programme ap-
peared to diminish the favourable short-term response to
self-managed exercise.
Research Implications: The findings of this research
suggest that exercise for depression in cancer is beneficial.
However, more information is required to understand the
optimal prescriptive factors that influence mood. The shift
in rate of response should be examined in more detail
including adherence.
As this was a feasibility study, a larger randomised trial
should be conducted to confirm the findings.
Practice Implications: Comorbid depression negatively
impacts on the quality of life of cancer survivors. Rates
of clinically disruptive depression are reportedly three
times higher than the noncancer population. Therefore,
there is a need to treat or manage depression. Exercise
appears to be an effective alternative to pharmacotherapy
or psychological counselling. This additional therapy
may be more suitable for some patients.
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BACKGROUND/PURPOSE: In recent years, the
American Society for Clinical Oncology and the Ameri-
can Society of Reproductive Medicine have recommended
that the impact of cancer treatment on fertility should be
discussed with all cancer patients of reproductive age
and that fertility preservation options should be offered
routinely.1–2 While fertility preservation options such as
oocyte or embryo cryopreservation with or without gesta-
tional surrogacy have made it possible for cancer patients
to become parents, the associated decision-making pro-
cess can involve significant ethical dilemmas.3 The poten-
tial dissonance involved in confronting a life-threatening
diagnosis while simultaneously considering the deeply
human desire to have a child presents a struggle for cancer
patients and clinicians.4 This struggle intensifies when the
patient has metastatic cancer and a genetic mutation. We
present several cases raising significant questions as to
whether current informed consent processes and legal
safeguards adequately address the ethical quandaries
inherent in oncofertility preservation. METHODS: Case
report describing patients with metastatic leiomyosarcoma
and BRCA positive metastatic breast cancer who pursued
fertility preservation. RESULTS: We present two cases:
Case 1: 52-year-old engaged woman with metastatic
leiomyosarcoma to lung on oral chemotherapy and s/p
mastectomy involving total removal of left scapula
considering gestational surrogacy with donor egg and
sperm provided by 65-year-old fiancé.
Case 2: 35-year-old single woman with a medical
history of triple-negative breast cancer and a psychiatric
history significant for panic disorder and possible
histrionic traits. She underwent genetic testing and was
found to have a BRCA1 mutation. At the time of her
diagnosis, she was 6 months into a new relationship. She
underwent neoadjuvant chemotherapy followed by
bilateral mastectomies and radiation therapy. She recurred
with metastatic disease to lung 3 months after completing
treatment. At that time, she requested a consult with the
hospital’s reproductive medicine specialist, supported by
her medical oncologist. The patient then underwent
embryo cryopreservation utilizing her boyfriend’s sperm
and selected a gestational carrier, the young fiancé of her
boyfriend’s cousin. In individual sessions with her social
work therapist, the patient conveyed a strong desire for
childbearing yet also expressed concerns about her
prognosis and the impact that her death might have on a
child. Several team members raised concerns about the
ethical dilemmas inherent in an embryo transfer and
sought a formal ethics consultation. It was ultimately
decided that the patient might benefit from a meeting with
her medical oncologist where she could ask direct
questions about her prognosis prior to proceeding with
the embryo transfer. The patient elected not to have her
boyfriend present for these discussions, resulting in
concerns about his understanding of her prognosis and
ability to make an informed decision regarding the
embryo transfer. Ultimately, the transfer (without pre-
implantation genetic diagnosis despite her BRCA positiv-
ity) occurred and resulted in a pregnancy. The patient’s
cancer continued to progress, and she ultimately died
within a month of her baby’s birth.
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